Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben F Ørntoft

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Ugeskrift for Laeger|March 11, 2003
[DNA microarrays (DNA chips) used in molecular medical research]Torben F Ørntoft
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Gene signatures for risk-adapted treatment of bladder cancerTorben F Ørntoft, Lars Dyrskjøt
Current Opinion in Urology|August 15, 2006
Recent developments in molecular profiling of bladder cancerTorben F Ørntoft, Karsten Zieger, Lars Dyrskjøt
Human Mutation|January 6, 2006
Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPsMette Gaustadnes, Torben F Ørntoft, Jens Ledet Jensen, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2003
Classification of Dukes' B and C colorectal cancers using expression arraysCasper Møller Frederiksen, Steen Knudsen, Søren Laurberg, et al.
Bioinformatics (Oxford, England)|December 8, 2010
Rseg--an R package to optimize segmentation of SNP array dataPhilippe Lamy, Carsten Wiuf, Torben F Ørntoft, et al.
International Journal of Cancer|July 29, 2009
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer developmentKarsten Zieger, Niels Marcussen, Michael Borre, et al.
The Prostate|January 15, 2005
Increase in amphiregulin and epiregulin in prostate cancer xenograft after androgen deprivation-impact of specific HER1 inhibitionNiels Tørring, Frederik Dagnaes Hansen, Boe Sandahl Sørensen, et al.
BMC Cancer|October 31, 2015
Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control studyMai-Britt W Ørntoft, Hans J Nielsen, Torben F Ørntoft, et al.
Ugeskrift for Laeger|April 6, 2019
[Infrastructure of clinical support and research in the Danish national genome centre]Torben F Ørntoft, Søren Brunak, Cathrine Jespergaard, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Ugeskrift for Laeger|March 11, 2003
[DNA microarrays (DNA chips) used in molecular medical research]Torben F Ørntoft
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Gene signatures for risk-adapted treatment of bladder cancerTorben F Ørntoft, Lars Dyrskjøt
Current Opinion in Urology|August 15, 2006
Recent developments in molecular profiling of bladder cancerTorben F Ørntoft, Karsten Zieger, Lars Dyrskjøt
Human Mutation|January 6, 2006
Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPsMette Gaustadnes, Torben F Ørntoft, Jens Ledet Jensen, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2003
Classification of Dukes' B and C colorectal cancers using expression arraysCasper Møller Frederiksen, Steen Knudsen, Søren Laurberg, et al.
Bioinformatics (Oxford, England)|December 8, 2010
Rseg--an R package to optimize segmentation of SNP array dataPhilippe Lamy, Carsten Wiuf, Torben F Ørntoft, et al.
International Journal of Cancer|July 29, 2009
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer developmentKarsten Zieger, Niels Marcussen, Michael Borre, et al.
The Prostate|January 15, 2005
Increase in amphiregulin and epiregulin in prostate cancer xenograft after androgen deprivation-impact of specific HER1 inhibitionNiels Tørring, Frederik Dagnaes Hansen, Boe Sandahl Sørensen, et al.
BMC Cancer|October 31, 2015
Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control studyMai-Britt W Ørntoft, Hans J Nielsen, Torben F Ørntoft, et al.
Ugeskrift for Laeger|April 6, 2019
[Infrastructure of clinical support and research in the Danish national genome centre]Torben F Ørntoft, Søren Brunak, Cathrine Jespergaard, et al.
Pageof 8